Interferon therapy for Kaposi sarcoma associated with acquired immunodeficiency syndrome: still a valid treatment option?
University Hospital of Nîmes , Nîmes, France .
Isabelle
I
Rouanet
Catherine
C
Lechiche
Régine
R
Doncesco
Jean Marc
JM
Mauboussin
Albert
A
Sotto
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy*; D019380:Anti-HIV Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D003131:Combined Modality Therapy; D005260:Female; D015658:HIV Infections / Q000188:drug therapy; D015497:HIV-1; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D012514:Sarcoma, Kaposi / Q000150:complications / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000150:complications* / Q000188:drug therapy; D016896:Treatment Outcome; D019562:Viral Load; D055815:Young Adult
D019380:Anti-HIV Agents; D000970:Antineoplastic Agents; D007372:Interferons